Getein Biotech Surges to Record Trading Volume as Institutional Buyers Boost Investor Confidence
Getein Biotech’s record‑high March 19 trading volume shows sharp investor interest and institutional inflows, hinting at growing confidence in its diversified biotech pipeline and China’s expanding healthcare market.
3 minutes to read